)
Edge11 Sep 2026
Texas Pacific Land Corporation: Keeper of the Permian Basin
Land once granted to a failed 19th-century railroad now generates royalties for Texas Pacific Land Corporation across the Permian Basin.
Hugel
Hugel (145020) investor relations material
Hugel Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary14 Aug, 2026
Executive summary
Net sales reached KRW 137.9bn in 2Q26, up 25.1% year-over-year.
Net income increased 17.1% year-over-year to KRW 44.7bn.
Operating profit was KRW 56.0bn, nearly flat year-over-year.
Revenue for the half-year ended June 30, 2026, was KRW 254.5 billion, with 57.8% from toxin products and 25.9% from fillers/skin boosters.
Major shareholder is Aphrodite Acquisition Holdings LLC, holding 43.53% of shares.
Financial highlights
Gross profit rose 22.1% year-over-year to KRW 105.8bn, with a gross margin of 76.7%.
SG&A expenses increased 66.0% year-over-year to KRW 49.7bn.
Pre-tax income grew 15.4% year-over-year to KRW 61.4bn.
Operating income for H1 2026: KRW 103.7 billion; net income: KRW 85.3 billion.
Cash and cash equivalents at June 30, 2026: KRW 259.6 billion.
Outlook and guidance
International sales mix increased to 67%, reflecting strong overseas demand.
Continued focus on expanding global market share, especially in the US, Europe, and China.
New product launches and regulatory approvals in multiple countries expected to drive future growth.
Ongoing investment in R&D and product pipeline, including next-generation botulinum toxin and skin booster products.
Botulinum toxin segment expected to continue driving growth, with 61% of sales mix.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Hugel
- Operating profit surged 54.5% year-over-year, driven by strong toxin and global sales growth.145020
Q3 2024 - Double-digit sales and profit growth in 4Q24, led by Toxin, Filler, and Cosmetics segments.145020Q4 2024
- H1 2024 revenue hit ₩169.7B, net income ₩59.7B, driven by global expansion and strong cash position.145020Q2 2024
- Global expansion, strong financials, and innovation drive leadership in medical aesthetics.145020J.P. Morgan HealthCare Conference 2025 presentation
- Targeting global leadership in aesthetics with innovative products and a hybrid U.S. sales model.145020JP Morgan Healthcare Conference 2026 presentation
- Q1 2026 delivered strong growth, led by botulinum toxin and international sales, with robust cash reserves.145020Q1 2026
- KRW 305.98bn YTD revenue, lower profit, strong global growth, and robust Derma Cosmetics.145020Q3 2025
- Double-digit sales growth led by botulinum toxin, derma cosmetics, and surging exports.145020Q2 2025
- Q1 2025 saw double-digit profit growth and global expansion, led by Asia Pacific sales.145020Q1 2025
Next Hugel earnings date
Q3 20266 Nov, 2026
Hugel
Next Hugel earnings date
Q3 20266 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage